Psoriasis Articles & Analysis
16 articles found
Researchers utilize these cells to explore the efficacy of drugs, assess toxicology, and understand the underlying mechanisms of skin diseases such as fibrosis, psoriasis, and melanoma. Furthermore, they are employed in the production of skin substitutes in regenerative medicine, offering hope for better treatments in skin grafting and reconstructive surgeries. ...
Targets include vWF, ADAMTS-5, IL17A/F, IL6R, CD19, CD20, PD-L1, CTLA4, etc., used in the treatment of osteoarthritis, rheumatoid arthritis, psoriasis, tumors, viral infections, ...
IL-17F can form heterodimers with IL-17A. In psoriasis patients, the content of IL-17F in plaques is higher than that in unaffected skin areas. ...
In humans, loss-of-function mutations in the gene encoding IL-36Ra lead to disordered IL-36R signaling, mainly manifested as generalized pustular psoriasis, indicating that IL-36 plays a critical role in the skin inflammation of psoriasis. ...
These diseases include: Asthma Psoriasis Lupus Rheumatoid arthritis Multiple sclerosis ...
Acanthosis nigricans Erythrasma Inverse psoriasis Tinea corporis Use the Differential Builder in VisualDx to help you. ...
ByVisualDx
By the time certain conditions are diagnosed in darker-skinned patients, the disorders are often more advanced. Nail psoriasis, for example, more severely impacts patients of darker skin and is diagnosed later. ...
ByVisualDx
A global partner is being sought for AxisBiotix-PS. The psoriasis treatment generated £75,000 in eight months. That is not doing much to reduce the cash outflow of the business. ...
Secukinumab, an IL-17A sequestering agent used in treating psoriasis, was selected as a repurposed candidate to address the sequential inflammatory disorders that follow the first metabolic insult. ...
The world's leading researchers joined Immunai’s second symposium dedicated to applications of Machine Learning (ML) in biology. The line-up of talks demonstrated innovative research taking place at the intersection of immunology and machine learning. ML is becoming an essential tool in every aspect of immunology. Our speakers shared their work on how they leveraged ML in their research, ...
ByImmunai
The comedogenic scale is a “measure” of how ingredients found in common skin care products will impact your pores. This scale is particularly useful when looking at products that you will apply to heal dry skin patches on your face. The scale is fairly simple to use and is broken down into a 6-level rating from 0 to 5. Rating of 0 - Does not clog pores. Rating of 1 – Low ...
It helps with chronic skin problems like eczema, psoriasis, and prevents the dry, itchy skin, common in diabetes patients. ...
Swapping handpieces or adding on attachments to the handpiece allows for increased uses including wounds, ulcers, warts, dermatological conditions like Psoriasis as well as venous insufficiency and fungal ...
Phototherapy has been used worldwide for nearly a century to treat chronic skin conditions such as psoriasis, vitiligo and severe eczema. While many treatments decrease the overall immune system. ...
The plan is to run one or two more trials and then approach the US Food and Drug Administration in 2020.” Taking on psoriasis and eczema. “We have recently conducted promising animal studies looking at topical administration of cyclosporine with our technology in psoriasis and eczema. ...
A second patent, US Patent 10,231,941 B2, is to directly treat fibrosis, NASH and liver cancer. Introduction to SFA Psoriasis and Autoimmune Disease Program. Psoriasis and Autoimmune Disease Program The FDA has approved entry into Phase 2a with our drug for psoriasis, and we have an IND approved and a Phase 1b clinical trial in patients ...